comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 04:13:49 - browse：8126

In this photo illustration, Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp. — Scott Olson/Getty Images

WASHINGTON — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends.

The negotiated prices won’t take effect until 2026.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

explore

leisure time

WSS

AI can’t replace a physician’s gut feeling

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Wisconsin governor employs partial veto to fund schools for 4 centuries

Rikers Island jail violence not addressed, NYC should be held in contempt: Fed monitor

Sanders adds drug shortage policies to pandemic preparedness bill

focus

comprehensive

entertainment

At least 13 dead in Texas as scorching temps continue

Wisconsin governor employs partial veto to fund schools for 4 centuries

Medical leaders decry Supreme Court decision on affirmative action

As digital health tech proliferates, a new institute aims to cut through hype

What does generative AI mean for health care? We asked experts

Sanders adds drug shortage policies to pandemic preparedness bill

Guidelines to prevent youth baseball injuries need more muscle

Biden tests positive for Covid

State Dept. review finds Biden bears some blame for Afghanistan failures

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

focus

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

At Orexo, a ‘turning point’ for everything but digital health

The aspartame in Diet Coke probably isn’t giving you cancer

In early work, researchers turn to CRISPR to treat Alzheimer's

WHO calls for emergency meeting on new China virus, as cases spread

hotspot

explore

leisure time

knowledge